Loading...

Timothy J Triche, MD, PhD

TitleProfessor of Pathology
InstitutionUniversity of Southern California
DepartmentPediatrics
AddressCHL Mail Stop 43
Off Campus
Los Angeles CA 90089
Phone+1 323 361 4516
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    My research focuses on genetic aspects of cancer biology and their biologic consequences. Current research emphasizes whole genome approaches to gene expression profiling and genomic polymorphisms using DNA microarrays and software developed by our group to analyze this data. Laboratory studies typically utilize tumor cell lines expressing transfected genes, or with silenced genes. Gene targets and biologically active small molecules are often analyzed in biologic context by these same methods. Clinical correlative studies utilize tumor tissue with linked clinical data. Recently, these methods have been applied to studies of age related macular degeneration, as part of the Beckman Macular Research Center at the Doheny Eye Institute, Keck School of Medicine.


    Collapse Research 
    Collapse Research Activities and Funding
    Nanoparticle Delivery System for Ewing Sarcoma Treatment
    NIH/NCI R41CA203457Apr 15, 2016 - Mar 31, 2017
    Role: Co-Principal Investigator
    Translation of Predictive Cancer Biomarkers into Clinical Practice
    NIH/NCI RC2CA148216Sep 29, 2009 - Aug 31, 2012
    Role: Co-Principal Investigator
    Diagnostic and Prognostic Sarcoma Signatures
    NIH/NCI U01CA114757Sep 27, 2005 - May 31, 2010
    Role: Principal Investigator
    GENE EXPRESSION IN SARCOMAS OF CHILDHOOD AND ADOLESCENCE
    NIH/NCI U01CA088199Sep 20, 2000 - Jan 31, 2007
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bolouri H, Farrar JE, Triche T, Ries RE, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Zhang J, Ma X, Liu Y, Liu Y, Auvil JMG, Davidsen TM, Gesuwan P, Hermida LC, Salhia B, Capone S, Ramsingh G, Zwaan CM, Noort S, Piccolo SR, Kolb EA, Gamis AS, Smith MA, Gerhard DS, Meshinchi S. Erratum: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nat Med. 2018 Apr 10; 24(4):526. PMID: 29634680.
      View in: PubMed
    2. Capone S, Connor KM, Colombo A, Li X, Triche T, Ramsingh G. Senescent human hematopoietic progenitors show elevated expression of transposable elements and inflammatory genes. Exp Hematol. 2018 Mar 13. PMID: 29549053.
      View in: PubMed
    3. Colombo AR, Zubair A, Thiagarajan D, Nuzhdin S, Triche T, Ramsingh G. Author Correction: Suppression of Transposable Elements in Leukemic Stem Cells. Sci Rep. 2018 Mar 06; 8(1):4240. PMID: 29511219.
      View in: PubMed
    4. Sun W, Triche T, Malvar J, Gaynon P, Sposto R, Yang X, Bittencourt H, Place AE, Messinger Y, Fraser C, Dalla-Pozza L, Salhia B, Jones P, Wayne AS, Gore L, Cooper TM, Liang G. A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortium. Blood. 2018 Mar 08; 131(10):1145-1148. PMID: 29339403.
      View in: PubMed
    5. Bolouri H, Farrar JE, Triche T, Ries RE, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Zhang J, Ma X, Liu Y, Liu Y, Auvil JMG, Davidsen TM, Gesuwan P, Hermida LC, Salhia B, Capone S, Ramsingh G, Zwaan CM, Noort S, Piccolo SR, Kolb EA, Gamis AS, Smith MA, Gerhard DS, Meshinchi S. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nat Med. 2018 Jan; 24(1):103-112. PMID: 29227476.
      View in: PubMed
    6. Gore L, Triche T, Farrar JE, Wai D, Legendre C, Gooden GC, Liang WS, Carpten J, Lee D, Alvaro F, Macy ME, Arndt C, Barnette P, Cooper T, Martin L, Narendran A, Pollard J, Meshinchi S, Boklan J, Arceci RJ, Salhia B. A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML. Clin Epigenetics. 2017; 9:108. PMID: 29034009.
      View in: PubMed
    7. Merchant AA, Jorapur A, McManus A, Liu R, Krasnoperov V, Chaudhry P, Singh M, Harton L, Agajanian M, Kim M, Triche T, Druker BJ, Tyner JW, Gill PS. EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT. Blood Adv. 2017 Sep 12; 1(20):1635-1644. PMID: 29296810.
      View in: PubMed
    8. Colombo AR, Zubair A, Thiagarajan D, Nuzhdin S, Triche T, Ramsingh G. Suppression of Transposable Elements in Leukemic Stem Cells. Sci Rep. 2017 Aug 01; 7(1):7029. PMID: 28765607.
      View in: PubMed
    9. Farrar JE, Neuberg D, Triche T, Bodine DM. Response: Making "perfect" the enemy of good. Blood. 2017 08 31; 130(9):1168-1169. PMID: 28754684.
      View in: PubMed
    10. Chaudhry P, Singh M, Triche T, Guzman M, Merchant AA. GLI3 repressor determines Hedgehog pathway activation and is required for response to SMO antagonist glasdegib in AML. Blood. 2017 06 29; 129(26):3465-3475. PMID: 28487292.
      View in: PubMed
    11. Fortin JP, Triche T, Hansen KD. Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics. 2017 02 15; 33(4):558-560. PMID: 28035024.
      View in: PubMed
    12. Li WL, Buckley J, Sanchez-Lara PA, Maglinte DT, Viduetsky L, Tatarinova TV, Aparicio JG, Kim JW, Au M, Ostrow D, Lee TC, O'Gorman M, Judkins A, Cobrinik D, Triche T. A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families. J Mol Diagn. 2016 07; 18(4):480-93. PMID: 27155049.
      View in: PubMed
    13. Elmoneim AA, Heuston E, Wai DH, Triche T, Arceci RJ. Synergisitic and Antagonistic AML Cell Type-specific Responses to 5-Aza-2-deoxycitidine and 1-h-D-Arabinofuranoside. Anticancer Res. 2016 Feb; 36(2):691-6. PMID: 26851026.
      View in: PubMed
    14. Hingorani P, Missiaglia E, Shipley J, Anderson JR, Triche T, Delorenzi M, Gastier-Foster J, Wing M, Hawkins DS, Skapek SX. Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group. Clin Cancer Res. 2015 Oct 15; 21(20):4733-9. PMID: 26473193; PMCID: PMC4610152 [Available on 10/15/16].
    15. Venkatramani R, Triche T, Wang L, Shimada H, Mascarenhas L. Insulin-like Growth Factor 2 Gene Expression Molecularly Differentiates Pleuropulmonary Blastoma and Embryonal Rhabdomyosarcoma. J Pediatr Hematol Oncol. 2015 Aug; 37(6):e356-60. PMID: 26056800; PMCID: PMC4506202.
    16. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25; 372(26):2481-98. PMID: 26061751.
      View in: PubMed
    17. Volchenboum SL, Andrade J, Huang L, Barkauskas DA, Krailo M, Womer RB, Ranft A, Potratz J, Dirksen U, Triche T, Lawlor ER. Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology Group. J Pathol Clin Res. 2015 Apr; 1(2):83-94. PMID: 26052443.
      View in: PubMed
    18. Moore JB, Loeb DM, Hong KU, Sorensen PH, Triche T, Lee DW, Barbato MI, Arceci RJ. Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line. Front Cell Dev Biol. 2015; 3:15. PMID: 25806369; PMCID: PMC4353378.
    19. Kang MH, Wang J, Makena MR, Lee JS, Paz N, Hall CP, Song MM, Calderon RI, Cruz RE, Hindle A, Ko W, Fitzgerald JB, Drummond DC, Triche T, Reynolds CP. Activity of MM-398, nanoliposomal irinotecan (nal-IRI), in Ewing's family tumor xenografts is associated with high exposure of tumor to drug and high SLFN11 expression. Clin Cancer Res. 2015 Mar 01; 21(5):1139-50. PMID: 25733708.
      View in: PubMed
    20. Mitra AP, Lam LL, Ghadessi M, Erho N, Vergara IA, Alshalalfa M, Buerki C, Haddad Z, Sierocinski T, Triche T, Skinner EC, Davicioni E, Daneshmand S, Black PC. Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer. J Natl Cancer Inst. 2014 Nov; 106(11). PMID: 25344601; PMCID: PMC4241889.
    21. Brohl AS, Solomon DA, Chang W, Wang J, Song Y, Sindiri S, Patidar R, Hurd L, Chen L, Shern JF, Liao H, Wen X, Gerard J, Kim JS, Lopez Guerrero JA, Machado I, Wai DH, Picci P, Triche T, Horvai AE, Miettinen M, Wei JS, Catchpool D, Llombart-Bosch A, Waldman T, Khan J. The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation. PLoS Genet. 2014 Jul; 10(7):e1004475. PMID: 25010205; PMCID: PMC4091782.
    22. Shah ED, Fisch BM, Arceci RJ, Buckley JD, Reaman GH, Sorensen PH, Triche T, Reynolds CP. DrugPath: a database for academic investigators to match oncology molecular targets with drugs in development. Cancer Chemother Pharmacol. 2014 May; 73(5):1089-93. PMID: 24663501.
      View in: PubMed
    23. Shi J, Marconett CN, Duan J, Hyland PL, Li P, Wang Z, Wheeler W, Zhou B, Campan M, Lee DS, Huang J, Zhou W, Triche T, Amundadottir L, Warner A, Hutchinson A, Chen PH, Chung BS, Pesatori AC, Consonni D, Bertazzi PA, Bergen AW, Freedman M, Siegmund KD, Berman BP, Borok Z, Chatterjee N, Tucker MA, Caporaso NE, Chanock SJ, Laird-Offringa IA, Landi MT. Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue. Nat Commun. 2014 Feb 27; 5:3365. PMID: 24572595.
      View in: PubMed
    24. Lay FD, Triche T, Tsai YC, Su SF, Martin SE, Daneshmand S, Skinner EC, Liang G, Chihara Y, Jones PA. Reprogramming of the human intestinal epigenome by surgical tissue transposition. Genome Res. 2014 Apr; 24(4):545-53. PMID: 24515120; PMCID: PMC3975055.
    25. May WA, Grigoryan RS, Keshelava N, Cabral DJ, Christensen LL, Jenabi J, Ji L, Triche T, Lawlor ER, Reynolds CP. Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines. PLoS One. 2013; 8(12):e80060. PMID: 24312454; PMCID: PMC3846563.
    26. Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, Patel L, Vergara IA, Davicioni E, Erho N, Ghadessi M, Jenkins RB, Triche T, Malik R, Bedenis R, McGregor N, Ma T, Chen W, Han S, Jing X, Cao X, Wang X, Chandler B, Yan W, Siddiqui J, Kunju LP, Dhanasekaran SM, Pienta KJ, Feng FY, Chinnaiyan AM. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet. 2013 Nov; 45(11):1392-8. PMID: 24076601; PMCID: PMC3812362.
    27. Wiseman SM, Haddad Z, Walker B, Vergara IA, Sierocinski T, Crisan A, Ghadessi M, Dao P, Zimmermann B, Triche T, Erho N, Davicioni E. Whole-transcriptome profiling of thyroid nodules identifies expression-based signatures for accurate thyroid cancer diagnosis. J Clin Endocrinol Metab. 2013 Oct; 98(10):4072-9. PMID: 23928671.
      View in: PubMed
    28. Reiff A, Weinberg KI, Triche T, Masinsin B, Mahadeo KM, Lin CH, Brown D, Parkman R. T lymphocyte abnormalities in juvenile systemic sclerosis patients. Clin Immunol. 2013 Oct; 149(1):146-55. PMID: 23994768.
      View in: PubMed
    29. Wilson RA, Teng L, Bachmeyer KM, Bissonnette ML, Husain AN, Parham DM, Triche T, Wing MR, Gastier-Foster JM, Barr FG, Hawkins DS, Anderson JR, Skapek SX, Volchenboum SL. A novel algorithm for simplification of complex gene classifiers in cancer. Cancer Res. 2013 Sep 15; 73(18):5625-32. PMID: 23913937; PMCID: PMC4233649.
    30. Fam HK, Walton C, Mitra SA, Chowdhury M, Osborne N, Choi K, Sun G, Wong PC, O'Sullivan MJ, Turashvili G, Aparicio S, Triche T, Bond M, Pallen CJ, Boerkoel CF. TDP1 and PARP1 deficiency are cytotoxic to rhabdomyosarcoma cells. Mol Cancer Res. 2013 Oct; 11(10):1179-92. PMID: 23913164.
      View in: PubMed
    31. Erho N, Crisan A, Vergara IA, Mitra AP, Ghadessi M, Buerki C, Bergstralh EJ, Kollmeyer T, Fink S, Haddad Z, Zimmermann B, Sierocinski T, Ballman KV, Triche T, Black PC, Karnes RJ, Klee G, Davicioni E, Jenkins RB. Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy. PLoS One. 2013; 8(6):e66855. PMID: 23826159; PMCID: PMC3691249.
    32. Mendoza-Naranjo A, El-Naggar A, Wai DH, Mistry P, Lazic N, Ayala FR, da Cunha IW, Rodriguez-Viciana P, Cheng H, Tavares Guerreiro Fregnani JH, Reynolds P, Arceci RJ, Nicholson A, Triche T, Soares FA, Flanagan AM, Wang YZ, Strauss SJ, Sorensen PH. ERBB4 confers metastatic capacity in Ewing sarcoma. EMBO Mol Med. 2013 Jul; 5(7):1087-102. PMID: 23681745; PMCID: PMC3721475.
    33. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 05 30; 368(22):2059-74. PMID: 23634996; PMCID: PMC3767041.
    34. Skapek SX, Anderson J, Barr FG, Bridge JA, Gastier-Foster JM, Parham DM, Rudzinski ER, Triche T, Hawkins DS. PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report. Pediatr Blood Cancer. 2013 Sep; 60(9):1411-7. PMID: 23526739; PMCID: PMC4646073.
    35. Triche T, Weisenberger DJ, Van Den Berg D, Laird PW, Siegmund KD. Low-level processing of Illumina Infinium DNA Methylation BeadArrays. Nucleic Acids Res. 2013 Apr; 41(7):e90. PMID: 23476028; PMCID: PMC3627582.
    36. Christensen L, Joo J, Lee S, Wai D, Triche T, May WA. FOXM1 is an oncogenic mediator in Ewing Sarcoma. PLoS One. 2013; 8(1):e54556. PMID: 23365673; PMCID: PMC3554707.
    37. Federman N, Chan J, Nagy JO, Landaw EM, McCabe K, Wu AM, Triche T, Kang H, Liu B, Marks JD, Denny CT. Enhanced growth inhibition of osteosarcoma by cytotoxic polymerized liposomal nanoparticles targeting the alcam cell surface receptor. Sarcoma. 2012; 2012:126906. PMID: 23024593; PMCID: PMC3447386.
    38. Wu CC, D'Argenio D, Asgharzadeh S, Triche T. TARGETgene: a tool for identification of potential therapeutic targets in cancer. PLoS One. 2012; 7(8):e43305. PMID: 22952662; PMCID: PMC3432038.
    39. Erho N, Buerki C, Triche T, Davicioni E, Vergara IA. Transcriptome-wide detection of differentially expressed coding and non-coding transcripts and their clinical significance in prostate cancer. J Oncol. 2012; 2012:541353. PMID: 22956952; PMCID: PMC3431106.
    40. Gadd S, Beezhold P, Jennings L, George D, Leuer K, Huang CC, Huff V, Tognon C, Sorensen PH, Triche T, Coffin CM, Perlman EJ. Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study. J Pathol. 2012 Sep; 228(1):119-30. PMID: 22374738.
      View in: PubMed
    41. Murphree AL, Triche T. An epigenomic mechanism in retinoblastoma: the end of the story? Genome Med. 2012 Feb 24; 4(2):15. PMID: 22364211; PMCID: PMC3392761.
    42. Vergara IA, Erho N, Triche T, Ghadessi M, Crisan A, Sierocinski T, Black PC, Buerki C, Davicioni E. Genomic "Dark Matter" in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers. Front Genet. 2012; 3:23. PMID: 22371711; PMCID: PMC3284255.
    43. Mitra SA, Mitra AP, Triche T. A central role for long non-coding RNA in cancer. Front Genet. 2012; 3:17. PMID: 22363342; PMCID: PMC3279698.
    44. Kaddis JS, Wai DH, Bowers J, Hartmann N, Baeriswyl L, Bajaj S, Anderson MJ, Getts RC, Triche T. Influence of RNA labeling on expression profiling of microRNAs. J Mol Diagn. 2012 Jan; 14(1):12-21. PMID: 22074760; PMCID: PMC3338349.
    45. Rodeberg DA, Garcia-Henriquez N, Lyden ER, Davicioni E, Parham DM, Skapek SX, Hayes-Jordan AA, Donaldson SS, Brown KL, Triche T, Meyer WH, Hawkins DS. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol. 2011 Apr 01; 29(10):1304-11. PMID: 21357792; PMCID: PMC3083998.
    46. Kapranov P, St Laurent G, Raz T, Ozsolak F, Reynolds CP, Sorensen PH, Reaman G, Milos P, Arceci RJ, Thompson JF, Triche T. The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA. BMC Biol. 2010 Dec 21; 8:149. PMID: 21176148; PMCID: PMC3022773.
    47. Cooper A, van Doorninck J, Ji L, Russell D, Ladanyi M, Shimada H, Krailo M, Womer RB, Hsu JH, Thomas D, Triche T, Sposto R, Lawlor ER. Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group. Clin Cancer Res. 2011 Jan 01; 17(1):56-66. PMID: 21047978; PMCID: PMC3711406.
    48. Potratz JC, Saunders DN, Wai DH, Ng TL, McKinney SE, Carboni JM, Gottardis MM, Triche T, Jürgens H, Pollak MN, Aparicio SA, Sorensen PH. Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas. Cancer Res. 2010 Nov 01; 70(21):8770-81. PMID: 20959493.
      View in: PubMed
    49. Anderson JR, Barr FG, Hawkins DS, Parham DM, Skapek SX, Triche T. Fusion-negative alveolar rhabdomyosarcoma: modification of risk stratification is premature. J Clin Oncol. 2010 Oct 10; 28(29):e587-8; author reply e589-90. PMID: 20697086.
      View in: PubMed
    50. Molyneux SD, Di Grappa MA, Beristain AG, McKee TD, Wai DH, Paderova J, Kashyap M, Hu P, Maiuri T, Narala SR, Stambolic V, Squire J, Penninger J, Sanchez O, Triche T, Wood GA, Kirschner LS, Khokha R. Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice. J Clin Invest. 2010 Sep; 120(9):3310-25. PMID: 20697156; PMCID: PMC2929719.
    51. Abdueva D, Wing M, Schaub B, Triche T, Davicioni E. Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays. J Mol Diagn. 2010 Jul; 12(4):409-17. PMID: 20522636; PMCID: PMC2893624.
    52. Kang HG, Jenabi JM, Liu XF, Reynolds CP, Triche T, Sorensen PH. Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cells. Mol Cancer Ther. 2010 May; 9(5):1396-407. PMID: 20423994.
      View in: PubMed
    53. Jiang X, Gwye Y, Russell D, Cao C, Douglas D, Hung L, Kovar H, Triche T, Lawlor ER. CD133 expression in chemo-resistant Ewing sarcoma cells. BMC Cancer. 2010 Mar 26; 10:116. PMID: 20346143; PMCID: PMC2851692.
    54. van Doorninck JA, Ji L, Schaub B, Shimada H, Wing MR, Krailo MD, Lessnick SL, Marina N, Triche T, Sposto R, Womer RB, Lawlor ER. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol. 2010 Apr 20; 28(12):1989-94. PMID: 20308669; PMCID: PMC2860404.
    55. Wu CC, Asgharzadeh S, Triche T, D'Argenio DZ. Prediction of human functional genetic networks from heterogeneous data using RVM-based ensemble learning. Bioinformatics. 2010 Mar 15; 26(6):807-13. PMID: 20134029; PMCID: PMC2832827.
    56. Davicioni E, Anderson JR, Buckley JD, Meyer WH, Triche T. Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children's oncology group. J Clin Oncol. 2010 Mar 01; 28(7):1240-6. PMID: 20124188; PMCID: PMC3040045.
    57. Paoloni M, Davis S, Lana S, Withrow S, Sangiorgi L, Picci P, Hewitt S, Triche T, Meltzer P, Khanna C. Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression. BMC Genomics. 2009 Dec 23; 10:625. PMID: 20028558; PMCID: PMC2803201.
    58. Wang A, Alimova IN, Luo P, Jong A, Triche T, Wu L. Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation. FASEB J. 2010 Mar; 24(3):833-43. PMID: 19917671; PMCID: PMC2830139.
    59. Hu K, Lee C, Qiu D, Fotovati A, Davies A, Abu-Ali S, Wai D, Lawlor ER, Triche T, Pallen CJ, Dunn SE. Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas. Mol Cancer Ther. 2009 Nov; 8(11):3024-35. PMID: 19887553; PMCID: PMC2783569.
    60. Günther OP, Balshaw RF, Scherer A, Hollander Z, Mui A, Triche T, Freue GC, Li G, Ng RT, Wilson-McManus J, McMaster WR, McManus BM, Keown PA. Functional genomic analysis of peripheral blood during early acute renal allograft rejection. Transplantation. 2009 Oct 15; 88(7):942-51. PMID: 19935467.
      View in: PubMed
    61. Lin D, Hollander Z, Ng RT, Imai C, Ignaszewski A, Balshaw R, Freue GC, Wilson-McManus JE, Qasimi P, Meredith A, Mui A, Triche T, McMaster R, Keown PA, McManus BM. Whole blood genomic biomarkers of acute cardiac allograft rejection. J Heart Lung Transplant. 2009 Sep; 28(9):927-35. PMID: 19716046.
      View in: PubMed
    62. Evdokimova V, Tognon C, Ng T, Ruzanov P, Melnyk N, Fink D, Sorokin A, Ovchinnikov LP, Davicioni E, Triche T, Sorensen PH. Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell. 2009 May 05; 15(5):402-15. PMID: 19411069.
      View in: PubMed
    63. Davicioni E, Anderson MJ, Finckenstein FG, Lynch JC, Qualman SJ, Shimada H, Schofield DE, Buckley JD, Meyer WH, Sorensen PH, Triche T. Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group. Am J Pathol. 2009 Feb; 174(2):550-64. PMID: 19147825; PMCID: PMC2630563.
    64. Zagar TM, Triche T, Kinsella TJ. Extraosseous Ewing's sarcoma: 25 years later. J Clin Oncol. 2008 Sep 10; 26(26):4230-2. PMID: 18779607.
      View in: PubMed
    65. Ren YX, Finckenstein FG, Abdueva DA, Shahbazian V, Chung B, Weinberg KI, Triche T, Shimada H, Anderson MJ. Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations. Cancer Res. 2008 Aug 15; 68(16):6587-97. PMID: 18701482.
      View in: PubMed
    66. Douglas D, Hsu JH, Hung L, Cooper A, Abdueva D, van Doorninck J, Peng G, Shimada H, Triche T, Lawlor ER. BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression. Cancer Res. 2008 Aug 15; 68(16):6507-15. PMID: 18701473; PMCID: PMC2570201.
    67. Neale G, Su X, Morton CL, Phelps D, Gorlick R, Lock RB, Reynolds CP, Maris JM, Friedman HS, Dome J, Khoury J, Triche T, Seeger RC, Gilbertson R, Khan J, Smith MA, Houghton PJ. Molecular characterization of the pediatric preclinical testing panel. Clin Cancer Res. 2008 Jul 15; 14(14):4572-83. PMID: 18628472; PMCID: PMC4209898.
    68. Pique-Regi R, Monso-Varona J, Ortega A, Seeger RC, Triche T, Asgharzadeh S. Sparse representation and Bayesian detection of genome copy number alterations from microarray data. Bioinformatics. 2008 Feb 01; 24(3):309-18. PMID: 18203770; PMCID: PMC2704547.
    69. Lewinger JP, Conti DV, Baurley JW, Triche T, Thomas DC. Hierarchical Bayes prioritization of marker associations from a genome-wide association scan for further investigation. Genet Epidemiol. 2007 Dec; 31(8):871-82. PMID: 17654612.
      View in: PubMed
    70. Abdueva D, Wing MR, Schaub B, Triche T. Experimental comparison and evaluation of the Affymetrix exon and U133Plus2 GeneChip arrays. PLoS One. 2007 Sep 19; 2(9):e913. PMID: 17878948; PMCID: PMC1976394.
    71. Santos ND, Habibi G, Wang M, Law JH, Andrews HN, Wei D, Triche T, Dedhar S, Dunn SE. Urokinase-type Plasminogen Activator (uPA) is Inhibited with QLT0267 a Small Molecule Targeting Integrin-linked Kinase (ILK). Transl Oncogenomics. 2007; 2:85-97. PMID: 23645983; PMCID: PMC3634623.
    72. Luo P, Wang A, Payne KJ, Peng H, Wang JG, Parrish YK, Rogerio JW, Triche T, He Q, Wu L. Intrinsic retinoic acid receptor alpha-cyclin-dependent kinase-activating kinase signaling involves coordination of the restricted proliferation and granulocytic differentiation of human hematopoietic stem cells. Stem Cells. 2007 Oct; 25(10):2628-37. PMID: 17628022.
      View in: PubMed
    73. Keshelava N, Davicioni E, Wan Z, Ji L, Sposto R, Triche T, Reynolds CP. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide. J Natl Cancer Inst. 2007 Jul 18; 99(14):1107-19. PMID: 17623797.
      View in: PubMed
    74. Parham DM, Qualman SJ, Teot L, Barr FG, Morotti R, Sorensen PH, Triche T, Meyer WH. Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. Am J Surg Pathol. 2007 Jun; 31(6):895-901. PMID: 17527077.
      View in: PubMed
    75. Kang HG, Jenabi JM, Zhang J, Keshelava N, Shimada H, May WA, Ng T, Reynolds CP, Triche T, Sorensen PH. E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res. 2007 Apr 01; 67(7):3094-105. PMID: 17409416; PMCID: PMC3906735.
    76. Tedeschi-Blok N, Buckley J, Varma R, Triche T, Hinton DR. Population-based study of early age-related macular degeneration: role of the complement factor H Y402H polymorphism in bilateral but not unilateral disease. Ophthalmology. 2007 Jan; 114(1):99-103. PMID: 17198853.
      View in: PubMed
    77. Wang JG, Barsky LW, Davicioni E, Weinberg KI, Triche T, Zhang XK, Wu L. Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin-dependent kinase-activating kinase binding and phosphorylation of PML/RARalpha. FASEB J. 2006 Oct; 20(12):2142-4. PMID: 16935935.
      View in: PubMed
    78. Davicioni E, Finckenstein FG, Shahbazian V, Buckley JD, Triche T, Anderson MJ. Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. Cancer Res. 2006 Jul 15; 66(14):6936-46. PMID: 16849537.
      View in: PubMed
    79. Yu Y, Davicioni E, Triche T, Merlino G. The homeoprotein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis. Cancer Res. 2006 Feb 15; 66(4):1982-9. PMID: 16488997.
      View in: PubMed
    80. Evdokimova V, Ruzanov P, Anglesio MS, Sorokin AV, Ovchinnikov LP, Buckley J, Triche T, Sonenberg N, Sorensen PH. Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species. Mol Cell Biol. 2006 Jan; 26(1):277-92. PMID: 16354698; PMCID: PMC1317623.
    81. Jin W, Kim BC, Tognon C, Lee HJ, Patel S, Lannon CL, Maris JM, Triche T, Sorensen PH, Kim SJ. The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-beta signaling by inactivating the TGF-beta type II receptor. Proc Natl Acad Sci U S A. 2005 Nov 08; 102(45):16239-44. PMID: 16258068; PMCID: PMC1283417.
    82. Hu-Lieskovan S, Heidel JD, Bartlett DW, Davis ME, Triche T. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res. 2005 Oct 01; 65(19):8984-92. PMID: 16204072.
      View in: PubMed
    83. Man TK, Chintagumpala M, Visvanathan J, Shen J, Perlaky L, Hicks J, Johnson M, Davino N, Murray J, Helman L, Meyer W, Triche T, Wong KK, Lau CC. Expression profiles of osteosarcoma that can predict response to chemotherapy. Cancer Res. 2005 Sep 15; 65(18):8142-50. PMID: 16166288.
      View in: PubMed
    84. Popielarski SR, Hu-Lieskovan S, French SW, Triche T, Davis ME. A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 2. In vitro and in vivo uptake results. Bioconjug Chem. 2005 Sep-Oct; 16(5):1071-80. PMID: 16173782.
      View in: PubMed
    85. Hu-Lieskovan S, Zhang J, Wu L, Shimada H, Schofield DE, Triche T. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors. Cancer Res. 2005 Jun 01; 65(11):4633-44. PMID: 15930281.
      View in: PubMed
    86. Yanagawa B, Taylor L, Deisher TA, Ng R, Schreiner GF, Triche T, Yang D, McManus BM. Affymetrix oligonucleotide analysis of gene expression in the injured heart. Methods Mol Med. 2005; 112:305-20. PMID: 16010026.
      View in: PubMed
    87. Heidel JD, Hu S, Liu XF, Triche T, Davis ME. Lack of interferon response in animals to naked siRNAs. Nat Biotechnol. 2004 Dec; 22(12):1579-82. PMID: 15558046.
      View in: PubMed
    88. He Q, Peng H, Collins SJ, Triche T, Wu L. Retinoid-modulated MAT1 ubiquitination and CAK activity. FASEB J. 2004 Nov; 18(14):1734-6. PMID: 15345685.
      View in: PubMed
    89. Zhang J, Hu S, Schofield DE, Sorensen PH, Triche T. Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas. Cancer Res. 2004 Sep 01; 64(17):6026-34. PMID: 15342383.
      View in: PubMed
    90. Zhang S, He Q, Peng H, Tedeschi-Blok N, Triche T, Wu L. MAT1-modulated cyclin-dependent kinase-activating kinase activity cross-regulates neuroblastoma cell G1 arrest and neurite outgrowth. Cancer Res. 2004 May 01; 64(9):2977-83. PMID: 15126328.
      View in: PubMed
    91. Levitt RJ, Buckley J, Blouin MJ, Schaub B, Triche T, Pollak M. Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression. Biochem Biophys Res Commun. 2004 Apr 02; 316(2):421-8. PMID: 15020235.
      View in: PubMed
    92. James AC, Veitch JG, Zareh AR, Triche T. Sensitivity and specificity of five abundance estimators for high-density oligonucleotide microarrays. Bioinformatics. 2004 May 01; 20(7):1060-5. PMID: 14764574.
      View in: PubMed
    93. McManus BM, Yanagawa B, Rezai N, Luo H, Taylor L, Zhang M, Yuan J, Buckley J, Triche T, Schreiner G, Yang D. Genetic determinants of coxsackievirus B3 pathogenesis. Ann N Y Acad Sci. 2002 Dec; 975:169-79. PMID: 12538163.
      View in: PubMed
    94. Wang J, Barsky LW, Shum CH, Jong A, Weinberg KI, Collins SJ, Triche T, Wu L. Retinoid-induced G1 arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of retinoic acid receptor alpha. J Biol Chem. 2002 Nov 08; 277(45):43369-76. PMID: 12213824.
      View in: PubMed
    95. Barr FG, Qualman SJ, Macris MH, Melnyk N, Lawlor ER, Strzelecki DM, Triche T, Bridge JA, Sorensen PH. Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions. Cancer Res. 2002 Aug 15; 62(16):4704-10. PMID: 12183429.
      View in: PubMed
    96. Schofield D, Triche T. cDNA microarray analysis of global gene expression in sarcomas. Curr Opin Oncol. 2002 Jul; 14(4):406-11. PMID: 12130925.
      View in: PubMed
    97. Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche T, Barr FG. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol. 2002 Jun 01; 20(11):2672-9. PMID: 12039929.
      View in: PubMed
    98. Huang SH, Triche T, Jong AY. Infectomics: genomics and proteomics of microbial infections. Funct Integr Genomics. 2002 Apr; 1(6):331-44. PMID: 11957108.
      View in: PubMed